%0 Journal Article
%A Kalweit, Gabriel
%A Ullrich, Evelyn
%A Boedecker, Joschka
%A Mertelsmann, Roland
%A Kalweit, Maria
%T AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress.
%J Oxford open immunology
%V 6
%N 1
%@ 2633-6960
%C Oxford
%I Oxford University Press
%M DKFZ-2025-01092
%P iqaf004
%D 2025
%X The molecular complexity of cancer presents significant challenges to traditional therapeutic approaches, necessitating the development of innovative treatment strategies capable of addressing the disease's dynamic nature and resistance mechanisms. Data-driven methodologies, particularly those employing Artificial Intelligence (AI), hold substantial promise by advancing a comprehensive understanding of the intricate molecular and cellular mechanisms underlying cancer and supporting the development of adaptive, patient-specific therapeutic strategies. Initiated through the Mertelsmann Foundation, the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg im Breisgau, Germany, aims to drive progress in AI-driven oncology. CRIION fosters global collaboration through initiatives like the Intelligent Oncology Symposium and supports multidisciplinary projects designed to integrate AI innovations into clinical workflows.
%K AI in oncology (Other)
%K interdisciplinary collaboration (Other)
%K optimized cancer treatment (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40417176
%2 pmc:PMC12103913
%R 10.1093/oxfimm/iqaf004
%U https://inrepo02.dkfz.de/record/301584